Tag Archives: Putamen/metabolism/radionuclide imaging

First human evidence of d-amphetamine induced displacement of a D2/3 agonist radioligand: a [11C]-(+)-PHNO positron emission tomography study

Willeit M, Ginovart N, Graff A, Rusjan P, Vitcu I, Houle S, Seeman P, Wilson AA, Kapur S. First human evidence of d-amphetamine induced displacement of a D2/3 agonist radioligand: a [11C]-(+)-PHNO positron emission tomography study. Neuropsychopharmacology. January 2008;33(2):279-289. Full Text – Open Access Publication Date January 2008 How Analyze was Used “For manual analysis,…

Regional changes in [18F]dopa metabolism in the striatum in Parkinson’s disease

Morrish PK, Sawle GV, Brooks DJ. Regional changes in [18F]dopa metabolism in the striatum in Parkinson’s disease. Brain. December 1996;119 ( Pt 6):2097-2103. Full Text – Open Access Publication Date December 1996 How Analyze was Used “Analysis of data was performed on SUN Sparc workstations … using ANALYZE (ANALYZE 7.5 … (Robb and Hanson, 1991).”…

Striatal D2 receptor status in patients with Parkinson’s disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography

Brooks DJ, Ibanez V, Sawle GV, Playford ED, Quinn N, Mathias CJ, Lees AJ, Marsden CD, Bannister R, Frackowiak RSJ. Striatal D2 receptor status in patients with Parkinson’s disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography. Ann Neurol. February 1992;31(2):184-192. Publication Date February 1992 How Analyze was Used “Data…